# Faxton St. Lukes Healthcare IRB – FDA Inspection, Feb 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/faxton-st-lukes-healthcare-irb/c5eb9b71-634c-48e6-8530-5c8c010f1ba5
Source feed: FDA_Inspections

> FDA inspection 1166461 of Faxton St. Lukes Healthcare IRB, February 23, 2022. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166461
- Company Name: Faxton St. Lukes Healthcare IRB
- Inspection Date: 2022-02-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Citation Count: 0

## Related Documents

- [FDA Inspection 886543 - 2014-06-27](https://www.keypedia.com/records/fda_inspections/faxton-st-lukes-healthcare-irb/d0b14547-5614-4961-9631-95f9d4a6bd02)

Company: https://www.keypedia.com/companies/faxton-st-lukes-healthcare-irb/5c3bf921-c3d1-4e8e-a3ff-42e4f57b378b
